Submit Specimens client login

Expressions of Experience

Expression Analysis has a long-standing reputation for being the industry’s leading provider and early adopter. Take a look at some of our firsts…

October 2001

FIRST commercial Affymetrix provider with a “service-centered” business model.

September 2003

FIRST to submit microarray data electronically to the Federal Drug Administration (FDA).

May 2004

FIRST microarray processing facility to achieve compliance with Good Laboratory Practices (GLP).
FIRST microarray processing facility to become registered for Clinical Laboratory Improvement Amendments (CLIA) certification.
FIRST developer of a proficiency testing program for Affymetrix Microarray Labs.

May 2005

FIRST commercial provider on the Association of Biomedical Resource Facilities (ABRF) Microarray Research Group
FIRST provider for globin RNA reduction in blood specimens using Affymetrix peptide nucleic acid (PNA) oligos.

August 2005

FIRST developer of data analysis method based on Affymetrix probe performance.

January 2006

FIRST provider with scientists leading the MicroArray Quality Control project (MAQC-I) main manuscript and data analysis.

September 2006

FIRST provider with scientists co-leading the MAQC-II Clinical Working Group.
FIRST microarray service provider in the Personalized Medicine Coalition.
FIRST microarray service provider in the Coalition for 21st Century Medicine.

March 2007

FIRST provider of NuGEN solution for microarray studies with formalin-fixed, paraffin-embedded (FFPE) tissues.

June 2007

FIRST provider with a quality director leading the Clinical Laboratory Management Association.

July 2007

FIRST provider with scientists on the FDA-NCI-AACR Cancer Biomarkers Collaborative, established to develop a set of guidelines for integrating predictive biomarkers into clinical trials.

October 2007

FIRST provider with CSPro™ certification for all Illumina services.

April 2008

FIRST provider to assist Serious Adverse Events Consortium in the study to assess genetic predictors for drug induced liver injury.

September 2008

FIRST provider to develop and file IP on a GWAS data analysis method.

January 2009

FIRST provider with CSPro™ Certification for all Illumina services, after acquisition of a Genome Analyzer.

April 2009

FIRST provider to offer RainDance sequence enrichment technologies.

July 09

FIRST commercial service provider for Nanostring Technologies

December 2009

Expression Analysis and Experience Beyond Expression become Register Trademarks

February 2010

FIRSTservice provider to receive CSPro Certification on all Illumina Platforms

April 2010

FIRST commercial service provider for Fluidigm

May 2010

FIRST commercial service provider to partner with Pacific BioSciences

Over nine years of scientific leadership

Click Here to Learn More